{"id":27289,"date":"2024-10-09T15:02:32","date_gmt":"2024-10-09T13:02:32","guid":{"rendered":"https:\/\/ggba.swiss\/atinary-technologies-and-snapdragon-chemistry-partner-to-optimize-drug-development-with-ai\/"},"modified":"2024-10-09T15:05:06","modified_gmt":"2024-10-09T13:05:06","slug":"atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/","title":{"rendered":"Atinary Technologies et Snapdragon Chemistry s’associent pour d\u00e9velopper des m\u00e9dicaments gr\u00e2ce \u00e0 l’IA"},"content":{"rendered":"\n

Atinary Technologies<\/a>, un fournisseur de premier plan de plateformes de recherche et d\u00e9veloppement (R&D) bas\u00e9es sur l’IA, a conclu une collaboration strat\u00e9gique avec Snapdragon Chemistry<\/a>, une soci\u00e9t\u00e9 de Cambrex, afin de relever les d\u00e9fis complexes li\u00e9s au d\u00e9veloppement de m\u00e9dicaments. Ce partenariat a pour objectif d’int\u00e9grer la technologie Self-Driving Labs\u2122 (SDLabs\u2122) d’Atinary aux capacit\u00e9s avanc\u00e9es de Snapdragon en mati\u00e8re de d\u00e9veloppement de laboratoires et de processus, afin d’am\u00e9liorer la d\u00e9couverte et la production de m\u00e9dicaments.<\/p>\n\n\n\n

Snapdragon Chemistry, connue pour son expertise en mati\u00e8re de d\u00e9veloppement de proc\u00e9d\u00e9s en flux continu et d’API synth\u00e9tiques complexes, a int\u00e9gr\u00e9 avec succ\u00e8s sa plateforme logicielle propri\u00e9taire LabOS\u2122 aux SDLabs\u2122 d’Atinary. Cette collaboration a permis le d\u00e9veloppement d’un syst\u00e8me enti\u00e8rement automatis\u00e9 et pilot\u00e9 par l’IA pour l’optimisation de la synth\u00e8se d’oligonucl\u00e9otides en phase solide. En utilisant la plateforme d’IA d’Atinary, les efforts d’optimisation des processus de Snapdragon ont permis d’atteindre jusqu’\u00e0 18 % d’augmentation du rendement des produits et 22 % de r\u00e9duction des co\u00fbts par rapport aux m\u00e9thodes traditionnelles.<\/p>\n\n\n\n

Dans le communiqu\u00e9 de presse de la soci\u00e9t\u00e9, le Dr Hermann Tribukait, cofondateur et CEO d’Atinary, a soulign\u00e9 l’importance de cette collaboration pour acc\u00e9l\u00e9rer l’innovation dans les industries pharmaceutiques et biotechnologiques. \u00ab Nos solutions bas\u00e9es sur l’IA et les donn\u00e9es r\u00e9pondent aux d\u00e9fis complexes de la chimie et de la d\u00e9couverte mol\u00e9culaire plus rapidement que les m\u00e9thodes traditionnelles \u00bb, a-t-il d\u00e9clar\u00e9, soulignant ainsi le potentiel de transformation de ce partenariat.<\/p>\n\n\n\n

Des avanc\u00e9es significatives pour l’industrie pharmaceutique<\/h4>\n\n\n\n

L’infrastructure de R&D avanc\u00e9e de Snapdragon et sa capacit\u00e9 \u00e0 concevoir des r\u00e9acteurs autonomes jouent un r\u00f4le essentiel dans cette collaboration. Eric Fang, directeur g\u00e9n\u00e9ral de Snapdragon Chemistry, a exprim\u00e9 son enthousiasme pour ce partenariat, soulignant la vision commune des deux entreprises qui consiste \u00e0 rationaliser les pipelines de d\u00e9veloppement de m\u00e9dicaments et \u00e0 am\u00e9liorer les portefeuilles de R&D gr\u00e2ce \u00e0 des technologies bas\u00e9es sur l’IA.<\/p>\n\n\n\n

En mettant l’accent sur l’am\u00e9lioration de l’efficacit\u00e9 et la r\u00e9duction des co\u00fbts de fabrication des m\u00e9dicaments, cette collaboration entre Atinary et Snapdragon Chemistry promet des avanc\u00e9es significatives dans l’industrie pharmaceutique, au b\u00e9n\u00e9fice des clients des deux soci\u00e9t\u00e9s et en acc\u00e9l\u00e9rant le processus de d\u00e9veloppement des m\u00e9dicaments.<\/p>\n\n\n\n

Ce partenariat fait suite aux r\u00e9cents succ\u00e8s d’Atinary Technologies<\/a> dans le domaine de l’innovation mat\u00e9rielle et mol\u00e9culaire et \u00e9largit encore la port\u00e9e de sa plateforme d’IA sans code \u00e0 de multiples secteurs, y compris les produits pharmaceutiques, les biotechnologies, les produits chimiques et bien plus encore.<\/p>\n","protected":false},"excerpt":{"rendered":"

Atinary Technologies et Snapdragon Chemistry ont annonc\u00e9 une collaboration strat\u00e9gique visant \u00e0 int\u00e9grer la technologie d’optimisation des processus pilot\u00e9e par l’IA aux capacit\u00e9s de d\u00e9veloppement pharmaceutique avanc\u00e9es, dans le but de r\u00e9volutionner le d\u00e9veloppement des m\u00e9dicaments.<\/p>\n","protected":false},"author":6,"featured_media":27286,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1169,1209,1180,1188],"class_list":["post-27289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-biotech-fr-2","tag-chemicals-fr-2","tag-digital-health-fr-2","tag-healthcare-fr-2"],"acf":[],"yoast_head":"\nAtinary Technologies et Snapdragon Chemistry s'associent<\/title>\n<meta name=\"description\" content=\"Atinary Technologies et Snapdragon Chemistry ont annonc\u00e9 une collaboration strat\u00e9gique pour r\u00e9volutionner le d\u00e9veloppement des m\u00e9dicaments.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atinary Technologies et Snapdragon Chemistry s'associent\" \/>\n<meta property=\"og:description\" content=\"Atinary Technologies et Snapdragon Chemistry ont annonc\u00e9 une collaboration strat\u00e9gique pour r\u00e9volutionner le d\u00e9veloppement des m\u00e9dicaments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-09T13:02:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-09T13:05:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Atinary Technologies et Snapdragon Chemistry s’associent pour d\u00e9velopper des m\u00e9dicaments gr\u00e2ce \u00e0 l’IA\",\"datePublished\":\"2024-10-09T13:02:32+00:00\",\"dateModified\":\"2024-10-09T13:05:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/\"},\"wordCount\":512,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png\",\"keywords\":[\"Artificial Intelligence\",\"Biotech\",\"Chemicals\",\"Digital Health\",\"Healthcare\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/\",\"name\":\"Atinary Technologies et Snapdragon Chemistry s'associent\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png\",\"datePublished\":\"2024-10-09T13:02:32+00:00\",\"dateModified\":\"2024-10-09T13:05:06+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Atinary Technologies et Snapdragon Chemistry ont annonc\u00e9 une collaboration strat\u00e9gique pour r\u00e9volutionner le d\u00e9veloppement des m\u00e9dicaments.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"Atinary Technologies s'est associ\u00e9e \u00e0 Snapdragon Chemistry pour int\u00e9grer l'IA dans le d\u00e9veloppement de m\u00e9dicaments. | \u00a9 Atinary Technologies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atinary Technologies et Snapdragon Chemistry s’associent pour d\u00e9velopper des m\u00e9dicaments gr\u00e2ce \u00e0 l’IA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atinary Technologies et Snapdragon Chemistry s'associent","description":"Atinary Technologies et Snapdragon Chemistry ont annonc\u00e9 une collaboration strat\u00e9gique pour r\u00e9volutionner le d\u00e9veloppement des m\u00e9dicaments.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/","og_locale":"fr_FR","og_type":"article","og_title":"Atinary Technologies et Snapdragon Chemistry s'associent","og_description":"Atinary Technologies et Snapdragon Chemistry ont annonc\u00e9 une collaboration strat\u00e9gique pour r\u00e9volutionner le d\u00e9veloppement des m\u00e9dicaments.","og_url":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-10-09T13:02:32+00:00","article_modified_time":"2024-10-09T13:05:06+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Atinary Technologies et Snapdragon Chemistry s’associent pour d\u00e9velopper des m\u00e9dicaments gr\u00e2ce \u00e0 l’IA","datePublished":"2024-10-09T13:02:32+00:00","dateModified":"2024-10-09T13:05:06+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/"},"wordCount":512,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png","keywords":["Artificial Intelligence","Biotech","Chemicals","Digital Health","Healthcare"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/","url":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/","name":"Atinary Technologies et Snapdragon Chemistry s'associent","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png","datePublished":"2024-10-09T13:02:32+00:00","dateModified":"2024-10-09T13:05:06+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Atinary Technologies et Snapdragon Chemistry ont annonc\u00e9 une collaboration strat\u00e9gique pour r\u00e9volutionner le d\u00e9veloppement des m\u00e9dicaments.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Atinary-Snapdragon-1180x811-1.png","width":1180,"height":811,"caption":"Atinary Technologies s'est associ\u00e9e \u00e0 Snapdragon Chemistry pour int\u00e9grer l'IA dans le d\u00e9veloppement de m\u00e9dicaments. | \u00a9 Atinary Technologies"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/atinary-technologies-et-snapdragon-chemistry-sassocient-pour-developper-des-medicaments-grace-a-lia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Atinary Technologies et Snapdragon Chemistry s’associent pour d\u00e9velopper des m\u00e9dicaments gr\u00e2ce \u00e0 l’IA"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=27289"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27289\/revisions"}],"predecessor-version":[{"id":27291,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27289\/revisions\/27291"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/27286"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=27289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=27289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=27289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}